SFRP2 and pseudohypoparathyroidism type 1A: In particular, we found the highest level of SFRP2 mRNA expression in the POH participant, intermediate expression in the AHO participant with severe ossifications, and lower levels of expression in the remaining participants with minimal, moderate, or no ossifications.